Podcast by Managed Care Cast
Examining the Shift to Value-Based Kidney Care Delivery in 2021
On this episode of Managed Care Cast, we speak with the new chief financial officer of Strive Health, a value-based kidney care company that works with payers and providers to create an integrated care delivery system for chronic kidney disease (CKD) and end stage renal disease (ESRD). We discuss the changes coming to nephrology practices as well as new ways of looking at the whole patient to try and halt the slide to irreversible ESRD.
Podcast: This Week in Managed Care—FDA Address Vaccine Dose Schedules and Other Health News
This week, the top managed care news included FDA advising against changes to vaccine dose schedules; drop in mammography screenings during the first months of the pandemic; first anti-TIGIT therapy granted Breakthrough Therapy designation by the FDA.
Podcast: This Week in Managed Care—First COVID-19 Vaccine Shipments and Other Health News
This week, the top managed care news included the first coronavirus disease 2019 vaccine shipments arriving nationwide; FDA panel votes to expand use of heart failure drug; efforts to address social determinants of health amid the pandemic.
Addressing Social Determinants of Health During COVID-19
On this episode of Managed Care Cast, we speak with Bechara Choucair, MD, the chief health officer of Kaiser Permanente, about their social health playbook, which guides clinicians about how to help patients with their social health needs during the pandemic.
Advice for the Biden Administration About the Challenges in Health Care
As 2020 ends, the last interview in a year-long series running during the 25th anniversary of The American Journal of Managed Care® (AJMC®) is with the journal’s co-editors-in-chief: Michael E. Chernew, PhD, and A. Mark Fendrick, MD.
This episode of Managed Care Cast is a preview of that conversation, which appears in the December issue. Chernew and Fendrick discuss which issues they think President-elect Joe Biden should prioritize, including the sustainability of Medicare, a continued way forward for the Affordable Care Act, and value-based insurance design, particularly as the continued coronavirus disease 2019 pandemic continues to stress every aspect of health care.
Database Helps Clinicians Determine Whether COVID-19 Causes Diabetes
Diabetes is an established risk factor for more severe cases of coronavirus disease 2019 (COVID-19). But recently reported cases of COVID-19-related diabetes among those with no preexisting risk factors suggest the 2 conditions may have a bidirectional relationship.
Interested in these rare cases, which don’t appear to fit the typical 2 types of diabetes, Francesco Rubino, MD, a professor of metabolic and bariatric surgery at King’s College London, along with a cohort of clinicians from around the world, devised a global registry of COVID-19-related diabetes to better track and understand this condition.
The CoviDiab Registry was created to establish the extent and characteristics of new-onset, COVID-19-related diabetes, and to investigate its pathogenesis, management and outcomes. On this episode of Managed Care Cast, we speak with Rubino about these new cases, the registry’s progress, and future implications of COVID-19-related diabetes.